Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 33-1254732

EWING SARCOMA INSTITUTE INC

Tax-exempt · DALLAS, TX 75382

Financials

$50K$34K2024
Revenue Expenses · by fiscal year end
Financials of EWING SARCOMA INSTITUTE INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990-EZ$50,334$33,924$16,410$16,410$0$16,410
Financial details: 990-EZ for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$50,000
Program service revenue
$0
Investment income
$334
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$0
Salaries, compensation and benefits (total)
$0
Professional fees and payments to contractors
$32,719
Other expenses
$1,205
Program services (functional)
$21,268

Balance sheet and other

Total assets, start of year
$0
Total assets, end of year
$16,410
Total liabilities, end of year
$0
Net assets, end of year
$16,410
Cash, savings and investments
$16,410
Gross receipts
$50,334

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990-EZ for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
DR PATRICK GROHAREXECUTIVE DIRECTOR8$0
DR HEINRICH KOVAREUROPEAN EXECUTIVE DIRECTOR5$0
CHAD A BROWNSECRETARY, TREASURER, BOARD MEMBER8$0
CHARLES E NEARBURGBOARD MEMBER5$0
DR LEE J HELMANBOARD MEMBER2$0

Address and contacts

Address (IRS master file)
PO BOX 823085, DALLAS, TX 75382-3085
Signed the 990-EZ
CHAD A BROWN, TREASURER
Phone
(214) 667-2210
Return prepared by
EASY OFFICE DBA JITASA

Mission

ACCELERATE SCIENTIFIC DISCOVERY & DEVELOPMENT OF BREAKTHROUGH TREATMENTS FOR EWING SARCOMA PATIENTS.

990-EZ for the year ended December 31, 2024

Program accomplishments

  • GENERAL PROGRAM - IN ITS FOUNDING YEAR, THE INSTITUTE MAPPED OUT THE FULL LANDSCAPE OF STAKEHOLDERS ESSENTIAL TO ADVANCING PROGRESS AGAINST EWING SARCOMA. LEADERSHIP MET WITH RESEARCHERS, CLINICIANS, SCIENTISTS, INDUSTRY REPRESENTATIVES, AND PATIENT ADVOCATES, AND ENGAGED DIRECTLY WITH KEY EWING SARCOMA ORGANIZATIONS, PARTNERS, AND INITIATIVES WORKING IN THE FIELD. THROUGH THESE EFFORTS, THE INSTITUTE DEVELOPED A COMPREHENSIVE UNDERSTANDING OF THE CURRENT STATE OF EWING SARCOMA RESEARCH AND CARE, AND IDENTIFIED OPPORTUNITIES TO STRENGTHEN COORDINATION ACROSS TRADITIONALLY SILOED GROUPS. THIS FOUNDATIONAL WORK ESTABLISHED THE COLLABORATIVE ARCHITECTURE UPON WHICH THE INSTITUTE'S RESEARCH FUNDING AND SCIENTIFIC PROGRAMMING WILL BE BUILT IN SUBSEQUENT YEARS.
    Expenses $9,816
  • COMMUNITY & PARENT ENGAGEMENT - IN ITS FOUNDING YEAR, THE INSTITUTE LAUNCHED ITS COMMUNITY ENGAGEMENT PROGRAM BY UNITING THE HISTORICALLY FRAGMENTED EWING SARCOMA ADVOCATE AND PHILANTHROPIC COMMUNITIES IN SHARED PURPOSE. THE INSTITUTE MET WITH DOZENS OF FOUNDATIONS FOCUSED ON EWING SARCOMA AND PEDIATRIC CANCER TO BUILD PHILANTHROPIC ALIGNMENT AND IDENTIFY COORDINATED FUNDING STRATEGIES. IT ALSO ENGAGED DIRECTLY WITH MORE THAN TWENTY EWING SARCOMA PATIENTS AND FAMILIES TO ENSURE THE PATIENT AND CAREGIVER VOICE INFORMS THE INSTITUTE'S RESEARCH PRIORITIES AND PROGRAMMATIC DIRECTION. THROUGH THESE EFFORTS, THE INSTITUTE TRANSFORMED A DISPERSED LANDSCAPE OF ADVOCACY AND GIVING INTO AN ORGANIZED COMMUNITY POSITIONED TO DRIVE COLLECTIVE IMPACT.
    Expenses $6,544
  • STRATEGIC ADVISORY BOARD - A DEFINING ACCOMPLISHMENT OF THE INSTITUTE'S FOUNDING YEAR WAS THE IDENTIFICATION, RECRUITMENT, AND FORMAL SEATING OF ITS STRATEGIC ADVISORY BOARD, COMPRISED OF TWELVE OF THE WORLD'S LEADING EXPERTS IN EWING SARCOMA. INSTITUTE LEADERSHIP MAPPED THE GLOBAL LANDSCAPE OF SCIENTIFIC AND CLINICAL EXPERTISE IN THE DISEASE AND ENGAGED TOP RESEARCHERS AND CLINICIANS ACROSS LEADING INSTITUTIONS. THE RESULTING BOARD REPRESENTS THE FOREMOST AUTHORITIES ON EWING SARCOMA BIOLOGY, TRANSLATIONAL RESEARCH, AND CLINICAL CARE, PROVIDING THE INSTITUTE WITH UNPARALLELED SCIENTIFIC GUIDANCE ON THIS RARE DISEASE. ESTABLISHING THE STRATEGIC ADVISORY BOARD IN THE FIRST YEAR PROVIDED THE SCIENTIFIC CREDIBILITY AND EXPERT OVERSIGHT NEEDED TO GUIDE RESEARCH INVESTMENTS AND PROGRAMMATIC PRIORITIES FROM THE OUTSET.
    Expenses $4,908

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990-EZ on file
2023December 31, 2023May 15, 2024Check at the IRS

File the 2025 990-EZ for EWING SARCOMA INSTITUTE INC

Due May 15, 2026 · e-filed with the IRS by 990.tax, an IRS-authorized e-file provider

IRS record

EIN
33-1254732
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2025
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H30)
Assets (IRS master file)
$16,410
Income (IRS master file)
$50,334

Filing history

FormYear endedRevenueExpensesAssetsReturn
990-EZDecember 2024$50,334$33,924$16,410XML

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 33-1254732).

Questions about EWING SARCOMA INSTITUTE INC

What is the EIN of EWING SARCOMA INSTITUTE INC?
The employer identification number (EIN) of EWING SARCOMA INSTITUTE INC is 33-1254732.
Is EWING SARCOMA INSTITUTE INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2025.
Are donations to EWING SARCOMA INSTITUTE INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does EWING SARCOMA INSTITUTE INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of EWING SARCOMA INSTITUTE INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did EWING SARCOMA INSTITUTE INC last file with the IRS?
The latest return in the IRS public files is the 990-EZ for the year ended December 2024.
Who are the officers and directors of EWING SARCOMA INSTITUTE INC?
The 990-EZ for the year ended December 31, 2024 lists 5 people; 0 received compensation from the organization.
How much revenue does EWING SARCOMA INSTITUTE INC have?
On its 990-EZ for the year ended December 31, 2024 it reported revenue of $50,334, expenses of $33,924 and total assets of $16,410 at year end.

Other nonprofits in DALLAS

All nonprofits in DALLAS · Texas · Medical research